Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by

Jia-Hau Yen1, Wei-Chieh Huang2,3, Shu-Ching Lin1

  • 1Research Cancer Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.

Insights

Cryptotanshinone (CPT) converts tumor-associated macrophages (TAMs) from M2 to M1 phenotypes, inhibiting tumor growth. This natural compound offers a novel macrophage-based strategy for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Tumor-associated macrophages (TAMs) often exhibit M2/repair phenotypes, promoting tumor growth.
  • Repolarizing TAMs to M1/kill phenotypes is a promising cancer immunotherapy strategy.
  • Cryptotanshinone (CPT) is a natural compound with potential immunomodulatory effects.

Purpose of the Study:

  • To investigate the potential of CPT as an antitumor immune modulator.
  • To elucidate the mechanism by which CPT influences TAM polarization.
  • To evaluate the efficacy of CPT in preclinical models of triple-negative breast cancer (TNBC).

Main Methods:

  • Utilized an orthotopic TNBC implantation mouse model.
  • Co-cultured TNBC cells with CPT-treated macrophages.
  • Investigated CPT's effects on mitochondrial function, autophagy, and the ASK1/TRAF6 signaling pathway.
  • Assessed TAM polarization in response to CPT treatment.

Main Results:

  • CPT treatment effectively switched TAMs from M2 to M1 phenotype, leading to tumor regression.
  • CPT inhibited TNBC cell proliferation and motility in vitro.
  • CPT suppressed tumor formation in vivo and modulated mitochondrial oxidative phosphorylation and fusion.
  • CPT's mechanism involves autophagy and the TRAF6-ASK1 pathway, with differential effects on M1 and M2 macrophages.

Conclusions:

  • CPT acts as an antitumor immune modulator by repolarizing TAMs to an M1 phenotype.
  • CPT's mechanism involves regulating mitochondrial function and the ASK1 pathway.
  • CPT demonstrates therapeutic potential as a natural compound for cancer immunotherapy via macrophage-based strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K